Effectiveness and tolerability of ezetimibe in patients with primary hypercholesterolemia: pooled analysis of two phase II studies.

Bays, H E; Moore, P B; Drehobl, M A; Rosenblatt, S; Toth, P D; Dujovne, C A; Knopp, R H; Lipka, L J; Lebeaut, A P; Yang, B; Mellars, L E; Cuffie-Jackson, C; Veltri, E P

Bays, H E; Moore, P B; Drehobl, M A; Rosenblatt, S; Toth, P D; Dujovne, C A; Knopp, R H; Lipka, L J; Lebeaut, A P; Yang, B; Mellars, L E; Cuffie-Jackson, C; Veltri, E P.

Bays HE; Louisville Metabolic and Atherosclerosis Research Center Louisville, Kentucky, USA.

Clin Ther ; 23(8): 1209-30, 2001 Aug.

Article en En | MEDLINE | ID: mdl-11558859

Asunto(s)

Anticolesterolemiantes/uso terapéutico; Azetidinas/uso terapéutico; LDL-Colesterol/sangre; Hipercolesterolemia/tratamiento farmacológico; Adolescente; Adulto; Anciano; Anticolesterolemiantes/efectos adversos; Azetidinas/efectos adversos; Método Doble Ciego; Ezetimiba; Femenino; Humanos; Hipercolesterolemia/sangre; Hipercolesterolemia/dietoterapia; Masculino; Persona de Mediana Edad

Search on Google

Imprimir

XML

PubMed Links

Banco de datos: MEDLINE Asunto principal: Azetidinas / Hipercolesterolemia / LDL-Colesterol / Anticolesterolemiantes Tipo de estudio: Clinical_trials Límite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Año: 2001 Tipo del documento: Article

Search on Google

Imprimir

XML

PubMed Links